bluetongu
viru
btv
infect
one
import
diseas
domest
livestock
antivir
avail
btv
diseas
paper
present
develop
optim
valid
vitro
cellbas
highthroughput
screen
ht
assay
use
luminescentbas
celltiterglo
reagent
identifi
novel
antivir
btv
condit
cytopath
effect
cpe
base
assay
optim
cell
densiti
cellswel
medium
contain
fb
multipl
infect
plate
zvalu
coeffici
variat
signaltobackground
ratio
assay
valid
use
compound
librari
fulli
valid
assay
use
screen
compound
collect
identifi
compound
cpe
inhibit
tenconcentr
dose
respons
assay
identifi
structur
ic
compound
group
six
analog
seri
correspond
six
scaffold
enrich
within
activ
set
compar
distribut
librari
cpebas
assay
develop
demonstr
robust
reliabl
applic
ht
campaign
make
signific
contribut
antivir
drug
discoveri
btv
diseas
bluetongu
viru
btv
nonenvelop
multilay
doublestrand
rna
viru
genu
orbiviru
famili
reovirida
one
largest
famili
virus
includ
major
human
pathogen
eg
rotaviru
vertebr
plant
insect
pathogen
btv
transmit
bite
midg
culicoid
includ
c
variipenni
c
imocola
mellor
btv
replic
vertebr
insect
host
caus
diseas
wild
rumin
econom
import
anim
includ
sheep
goat
cattl
domest
anim
around
world
mellor
mellor
wittmann
billionyear
loss
worldwid
maclachlan
osburn
mellor
et
al
due
econom
signific
btv
subject
extens
molecular
genet
structur
studi
repres
one
well
character
virus
antivir
drug
effect
control
measur
develop
btv
current
vector
control
vaccin
use
btv
viruslik
particl
two
main
prevent
strategi
implement
prevent
possibl
btv
epidem
blair
et
al
travanti
et
al
howev
strategi
demonstr
insuffici
due
chang
vector
habitat
new
viru
strain
outbreak
btv
mediterranean
basin
greatest
epizoot
diseas
record
show
btv
extend
rang
northward
area
europ
never
affect
persist
mani
locat
meiswinkel
et
al
epidem
link
recent
distribut
extens
major
vector
c
imicola
involv
novel
culicoid
vector
appar
abil
viru
overwint
absenc
adult
vector
mellor
wittmann
thu
urgent
develop
effect
antivir
drug
btv
infect
avoid
possibl
epidem
develop
robust
reliabl
biolog
assay
critic
antivir
drug
discoveri
tradit
antivir
drug
discoveri
assay
includ
cytopath
effect
cpe
base
assay
genom
andor
subgenom
repliconbas
assay
plaqu
form
assay
puigbasago
et
al
severson
et
al
severson
et
al
cpe
evid
btv
infect
vertebr
cell
hela
bsr
hek
includ
biochem
morpholog
hallmark
apoptosi
activ
dna
fragment
membran
bleb
cellular
shrinkag
li
et
al
btvinduc
cpe
andor
apoptosi
could
monitor
use
differ
cpe
apoptosi
detect
method
make
develop
robust
reliabl
assay
possibl
present
develop
robust
reliabl
cpebas
high
throughput
screen
ht
assay
antivir
drug
discoveri
btv
infect
identif
novel
antivir
compound
protect
host
cell
btv
infect
bsr
cell
line
deriv
cell
line
babi
hamster
kidney
bhk
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
supplement
fetal
calf
serum
fc
uml
penicillin
streptomycin
sigmaaldrich
chemic
co
st
loui
mo
unless
otherwis
note
cell
harvest
resuspend
assay
medium
dmem
streptomycin
iu
penicillinl
fb
plate
andor
compound
treatment
cell
incub
co
humid
time
period
note
stock
propag
bsr
cell
previous
describ
li
et
al
briefli
bsr
cell
grown
flask
confluent
infect
viru
multipl
infect
moi
h
incub
cell
harvest
centrifug
cell
pellet
resuspend
ml
media
sonic
cell
debri
centrifug
rpm
minut
supernat
aliquot
tube
save
btv
stock
cell
titrat
bsr
cell
use
tcid
assay
final
titer
tcid
ml
viru
titer
determin
bsr
cell
monolay
grown
plate
bsr
cell
seed
plate
incub
h
co
humid
volum
serial
dilut
viru
inocul
well
quadrupl
format
plate
incub
co
humid
h
cpe
observ
microscop
magnif
viru
titer
express
tcid
unit
per
ml
solut
carrier
control
consist
dimethyl
sulfoxid
dmso
dilut
complet
assay
media
dispens
cell
viru
control
well
black
clearbottom
tissu
cultur
treat
plate
corn
test
compound
dilut
media
dmso
concentr
total
volum
dispens
well
assay
plate
final
assay
volum
result
final
concentr
dmso
test
compound
compound
dilut
addit
perform
beckman
coulter
fx
liquid
handler
brief
centrifug
assay
plate
transfer
cell
plate
facil
tenconcentr
dose
respons
assay
compound
ad
assay
media
twofold
serial
dilut
rang
valid
assay
larg
scale
ht
assay
cell
plate
plate
cell
densiti
cellswel
otherwis
note
assay
media
use
wellmat
bulk
dispens
matrix
inc
plate
incub
hr
co
humid
incub
thermoscientif
cell
infect
btv
moi
otherwis
note
text
btv
stock
tcid
ml
first
dilut
assay
media
contain
tcid
ml
viru
dilut
viru
ad
compound
well
viru
control
well
media
mock
infect
ad
cell
control
well
addit
carri
use
matrix
wellmat
hous
class
ii
biosafeti
cabinet
within
biosafeti
level
laboratori
plate
incub
anoth
h
co
humid
celltiterglo
buffer
lyophil
celltiterglo
substrat
promega
inc
madison
usa
thaw
equilibr
room
temperatur
prior
use
homogen
celltiterglo
reagent
solut
reconstitut
mix
lyophil
enzymesubstr
buffer
reagent
accord
manufactur
instruct
meanwhil
assay
plate
also
equilibr
room
temperatur
minut
equal
volum
celltiterglo
reagent
ad
well
plate
incub
min
room
temperatur
stabil
luminesc
signal
luminesc
measur
use
perkin
elmer
envis
multilabel
reader
integr
time
order
identifi
common
structur
element
within
identifi
activ
hit
compound
set
cluster
use
cheminformat
tool
avail
leadscop
leadscop
inc
columbu
ohio
hierarch
cluster
analysi
perform
use
tanimoto
index
threshold
appli
complet
linkag
method
cluster
repres
substructur
identifi
common
motif
share
member
cluster
enrich
ratio
comput
cluster
substructur
order
predict
whether
substructur
may
consid
privileg
ht
campaign
thirti
two
control
well
contain
cell
well
contain
cell
viru
includ
assay
plate
control
use
calcul
zvalu
plate
normal
data
per
plate
basi
raw
data
import
activ
base
data
manag
softwar
idb
alameda
ca
determin
zvalu
signaltobackground
sb
fold
decreas
ratio
percent
inhibit
assay
compound
result
express
percent
inhibit
cpe
inhibit
cpe
equal
mean
cell
control
compound
show
greater
averag
cpe
inhibit
plu
three
time
standard
deviat
inhibit
viralinduc
cpe
compound
consid
hit
test
tenconcentr
dose
respons
assay
statist
calcul
zvalu
made
follow
mean
mean
luminesc
signal
cell
control
stddev
standard
deviat
luminesc
signal
cell
control
mean
b
mean
luminesc
signal
btv
infect
control
stddev
b
standard
deviat
luminesc
signal
viru
infect
control
sb
mean
mean
b
ghosh
et
al
zhang
et
al
assay
valid
step
perform
triplic
except
valid
screen
compound
perform
duplic
screen
nih
molecular
librari
small
molecul
repositori
mlsmr
compound
dose
respons
assay
carri
btv
infect
induc
apoptosi
andor
cpe
number
mammalian
cell
includ
vero
hela
bhkbsr
li
et
al
mortola
et
al
nagaleekar
et
al
schwartzcornil
et
al
characterist
apoptosi
cpe
includ
cell
shrinkag
membran
bleb
dna
fragment
shown
apoptot
pathway
elucid
li
et
al
mortola
et
al
nagaleekar
et
al
quantit
analysi
cpe
induc
btv
infect
shown
use
plate
bsr
cell
seed
densiti
cellswel
infect
btv
differ
moi
respect
differ
hour
post
infect
hpi
btvinduc
cpe
determin
use
celltiterglo
luminesc
cell
viabil
kit
homogen
method
determin
number
viabl
cell
cultur
base
quantit
atp
present
signal
presenc
metabol
activ
cell
singl
step
addmixmeasur
format
result
cell
lysi
gener
luminesc
signal
also
ideal
futur
larg
scale
ht
variou
compound
librari
signific
decreas
cell
viabil
btv
infect
cell
hpi
twofold
decreas
cell
viabil
btv
infect
cell
observ
three
moi
hpi
decreas
cell
viabil
much
appar
hpi
fold
decreas
ie
sb
ratio
moi
respect
figur
result
show
btv
infect
induc
cpe
quantit
especi
hpi
remark
high
sb
ratio
meanwhil
singl
step
cpebas
assay
suitabl
futur
ht
assay
although
optim
necessari
improv
cpebas
assay
primari
ht
assay
larg
scale
ht
compound
test
dissolv
dmso
solut
shown
high
dmso
concentr
dramat
effect
membran
permeabl
cell
viabil
viru
infect
mdck
cell
irvin
et
al
noah
et
al
thu
necessari
evalu
effect
dmso
cell
growth
cell
viabil
bsr
cell
seed
plate
cellswel
bsr
cell
treat
dmso
differ
concentr
rang
figur
h
incub
cell
viabil
determin
use
celltiterglo
reagent
effect
dmso
cell
viabil
compar
cell
viabil
dmso
treat
cell
rel
cell
viabil
cell
treat
dmso
bsr
cell
treat
dmso
lower
concentr
decreas
cell
viabil
contrast
slight
increas
cell
viabil
rang
cell
treat
dmso
concentr
howev
cell
treat
dmso
decreas
cell
viabil
consider
decreas
compar
cell
without
dmso
treatment
figur
result
support
design
dmso
concentr
ht
campaign
suitabl
screen
meanwhil
dmso
ad
cell
cultur
entir
screen
use
assay
optim
cell
densityth
seed
cell
densiti
import
avoid
possibl
cell
overgrowth
obtain
maximum
consist
luminesc
signal
strength
good
b
ratio
minimum
well
optim
seed
cell
densiti
bsr
cell
seed
plate
differ
cellswel
respect
cell
viabil
evalu
analyz
differ
time
post
seed
use
celltiterglo
reagent
fig
cell
densiti
cellwel
cell
growth
reach
plateau
h
post
seed
luminesc
signal
decreas
h
post
seed
cell
densiti
cellswel
cell
growth
reach
plateau
h
post
seed
luminesc
signal
increas
h
h
cellswel
densiti
show
maxim
luminesc
signal
ie
cell
viabil
chosen
optim
cell
densiti
subsequ
experi
growth
andor
viabil
also
affect
fb
concentr
cell
cultur
media
tradit
cell
cultur
medium
contain
higher
fb
keep
cell
grow
rapidli
howev
risk
overgrowth
may
lead
decreas
cell
viabil
high
also
compound
virus
known
bind
fb
therefor
would
show
fals
neg
screen
two
differ
fb
concentr
dmem
media
evalu
differ
seed
cell
densiti
concentr
seed
densiti
cellswel
show
similar
pattern
decreas
cell
viabil
observ
h
post
seed
cellswel
seed
densiti
although
cell
still
multipli
h
fb
cell
growth
fb
concentr
activ
compar
cell
growth
fb
thu
chose
fb
concentr
cellswel
cell
densiti
optim
cell
cultur
condit
subsequ
experi
optim
btv
infect
carri
achiev
rel
highest
luminesc
signal
lowest
moi
previou
experi
moi
luminesc
signal
decreas
level
similar
obtain
moi
observ
show
even
lower
moi
cpe
also
obviou
result
shown
thu
chose
five
low
moi
infect
bsr
cell
seed
optim
cell
densiti
cellswel
cell
incub
h
cell
viabil
evalu
use
celltiterglo
reagent
hpi
cell
viabil
folder
lower
moi
respect
compar
mock
infect
cell
hpi
fold
decreas
sb
ratio
moi
respect
fig
luminesc
signal
moi
compar
moi
good
sb
ratio
fit
standard
achiev
rel
high
signal
differ
lowest
moi
thu
moi
select
subsequ
experi
includ
primari
ht
assay
zvalu
analysi
design
evalu
assay
robust
enough
screen
ht
platform
zvalu
evalu
assay
signal
dynam
rang
data
variat
associ
sampl
measur
data
variat
associ
refer
control
measur
determin
zvalu
cpebas
assay
plate
run
three
differ
day
three
differ
assay
optim
condit
includ
cell
densiti
cellswel
fb
media
btv
infect
moi
final
luminesc
signal
read
hpi
plate
divid
four
quadrant
btv
infect
cell
posit
control
quadrant
iv
mock
infect
cell
neg
control
b
quadrant
ii
iii
plate
zvalu
analysi
perform
repeatedli
demonstr
reproduc
obtain
averag
zvalu
optim
assay
condit
use
formula
section
zhang
et
al
demonstr
assay
robust
suitabl
primari
ht
assay
furthermor
accord
experi
ht
set
zvalu
would
higher
assay
fulli
autom
cpebas
assay
optim
zvalu
determin
laboratori
assay
transfer
adapt
ht
center
southern
research
institut
assay
first
repeat
plate
use
autom
liquid
handl
equip
also
use
screen
larg
scale
compound
librari
section
integr
assay
onto
ht
platform
evalu
individu
step
procedur
load
plate
cell
final
data
analysi
examin
intraand
interrun
variat
includ
well
well
plate
plate
day
day
variabl
care
evalu
run
three
z
plate
three
separ
day
total
nine
plate
determin
assay
suffici
robust
screen
larg
compound
librari
result
show
averag
zvalu
repeat
averag
coeffici
variat
cv
cell
control
sb
ratio
result
demonstr
qualiti
control
paramet
assay
met
requir
includ
cv
zvalu
sb
interrun
reproduc
final
valid
step
screen
small
compound
set
compound
two
differ
time
statist
compar
result
reproduc
compound
screen
concentr
two
duplic
screen
differ
time
qualiti
control
assess
sever
differ
point
within
assay
process
valu
cell
control
btv
infect
control
well
review
determin
viabil
plate
compound
data
valu
duplic
screen
also
compar
determin
consist
averag
zvalu
plate
cv
sb
hit
rate
compound
inhibit
cpe
show
tabl
inhibit
cpe
equal
averag
cpe
inhibit
plu
three
time
standard
deviat
inhibit
compound
duplic
screen
reproduc
signal
window
robust
duplic
screen
demonstr
similar
z
valu
vs
cv
cell
control
vs
viru
control
vs
sb
ratio
averag
plate
vs
tabl
overal
observ
averag
hit
rate
compound
inhibit
btvinduc
cpe
respect
pearson
product
moment
correl
high
compar
duplic
screen
correl
coeffici
p
valu
indic
differ
duplic
screen
reproduc
robust
cpebas
assay
demonstr
valid
compound
mlsmr
screen
compound
mlsmr
collect
gener
group
follow
four
categori
specialti
set
ss
known
drug
toxin
b
target
librari
tl
kinas
gpcr
inhibitor
c
natur
product
np
divers
compound
dc
repres
gener
chemic
divers
compound
select
base
physicochem
properti
cutoff
appli
includ
mw
clogp
hba
hbd
compound
screen
use
valid
cpebas
assay
six
separ
run
exact
optim
experiment
condit
hit
identifi
base
inhibit
viru
induc
cpe
equal
averag
inhibit
plu
three
time
standard
deviat
inhibit
compound
entir
mlsmr
screen
assay
robust
includ
averag
zvalu
sb
ratio
graphic
illustr
figur
averag
zvalu
entir
screen
figur
match
zvalu
obtain
duplic
valid
screen
averag
cv
cell
viru
infect
result
shown
b
ratio
figur
entir
screen
includ
cell
control
viru
infect
control
viru
infect
plu
drug
treatment
percentag
inhibit
viru
induc
cpe
compound
screen
plot
figur
compound
screen
identifi
hit
cpe
inhibit
hit
rate
compound
identifi
inhibit
viru
induc
cpe
tabl
figur
six
hundr
fiftyeight
compound
avail
test
use
tenconcentr
dose
respons
assay
dose
respons
test
hit
activ
set
compound
possess
ic
valu
less
select
purpos
structur
analysi
order
identifi
common
structur
element
within
activ
set
cluster
cluster
repres
substructur
identifi
common
motif
share
member
cluster
enrich
ratio
character
particular
substructur
defin
ratio
percentag
compound
contain
substructur
within
activ
set
compound
percentag
within
entir
librari
screen
compound
privileg
scaffold
contribut
activ
hit
typic
present
higher
percentag
among
activ
compound
compar
distribut
within
entir
screen
librari
select
scaffold
repres
hit
cluster
show
enrich
ratio
greater
list
decreas
order
cluster
size
scheme
privileg
scaffold
like
present
among
nonclust
activ
small
cluster
member
less
well
therefor
select
scaffold
pursu
includ
cluster
hit
well
nonclust
singleton
activ
structur
cpe
gener
term
use
describ
advers
effect
cell
post
viral
infect
cpe
involv
least
two
distinct
process
necrosi
apoptosi
variou
assay
avail
distinguish
two
mechan
measur
varieti
differ
marker
indic
number
dead
cell
cytotox
number
live
cell
viabil
mechan
cell
death
apoptosi
convent
cellbas
antivir
drug
screen
assay
develop
base
cell
viabil
assay
atpas
kinas
cytotox
introduct
cpebas
assay
use
atpluminesc
readout
celltiterglo
reagent
recent
report
made
ht
larg
compound
librari
possibl
sever
differ
antivir
assay
includ
antivir
ht
assay
influenza
viru
noah
et
al
severson
et
al
sarscov
yellow
fever
viru
gong
et
al
crimeancongo
hemorrhag
fever
viru
paraga
et
al
cpebas
antivir
assay
btv
also
show
feasibl
mix
measur
one
step
protocol
flexibl
stabl
luminesc
signal
meanwhil
toxic
compound
reduc
cell
viabil
also
exclud
cpebas
assay
cpebas
assay
also
easi
adapt
valid
ht
center
make
possibl
screen
larg
compound
librari
mlsmr
collect
assay
may
also
use
assay
base
cpe
induc
reovirus
arbovirus
assay
also
demonstr
robust
high
degre
reproduc
low
deviat
includ
reproduc
zvalu
high
sensit
low
background
sb
ratio
rang
typic
sb
ratio
greater
adequ
detect
window
zvalu
consid
robust
enough
ht
assay
zhang
et
al
duplic
valid
screen
cpebas
assay
use
test
compound
librari
primari
ht
assay
mlsmr
demonstr
assay
suffici
robust
reproduc
ht
platform
similar
statist
assay
perform
valu
includ
zvalu
cv
cell
control
sb
tabl
cv
viru
infect
control
higher
natur
viru
infect
cell
due
complex
natur
viru
infect
process
sb
ratio
form
one
valid
screen
lower
requir
howev
consist
zvalu
valid
screen
indic
assay
robust
use
ht
inde
similar
zvalu
cv
sb
ratio
also
obtain
assay
paramet
primari
ht
demonstr
assay
reproduc
reliabl
three
screen
show
similar
hit
rate
hit
inhibit
cpe
tabl
similar
hit
rate
observ
number
ht
assay
variou
virus
includ
hit
rate
two
assay
identif
influenza
inhibitor
respect
noah
et
al
severson
et
al
sarscov
ht
although
possibl
increas
hit
rate
manipul
assay
condit
includ
dose
higher
compound
concentr
ie
andor
reduc
assay
length
h
confid
hit
identifi
primari
ht
accur
evidenc
correspond
hit
correl
duplic
k
screen
confirm
dose
respons
assay
hit
compound
ic
less
cluster
identifi
common
substructur
among
scheme
list
substructur
highest
enrich
among
activ
hit
compar
distribut
entir
librari
screen
cluster
identifi
includ
mononuclear
heterocyl
compound
thiophen
thiazol
deriv
bicycl
compound
pyrimidin
fuse
pyrazol
ring
system
scaffold
similar
core
scaffold
thienooxazinon
consid
cyclic
deriv
ortho
sustitut
thiophen
deriv
repres
note
scaffold
may
consid
small
group
close
relat
analog
seri
nearli
member
seri
activ
develop
cpebas
assay
btv
infect
ht
mlsmr
librari
provid
uniqu
model
system
identifi
number
novel
antivir
compound
protect
host
cell
btv
infect
btv
prototyp
viru
genu
orbiviru
within
famili
reovirida
btv
consid
one
import
diseas
domest
livestock
subject
intens
molecular
studi
last
three
decad
one
best
understood
virus
molecular
structur
level
roy
member
reovirus
arbovirus
btv
must
capabl
suffici
flexibl
allow
replic
evolutionarili
distant
host
also
appli
reovirus
arbovirus
includ
member
famili
togavirida
flavivirida
bunyavirida
rhabdovirida
reovirida
sinc
antivir
compound
identifi
could
protect
host
cell
btvinduc
cpe
respons
compound
might
also
protect
host
cell
reovirus
arbovirus
infect
meanwhil
compound
identifi
use
assay
could
use
chemic
probe
studi
virushost
interact
thu
develop
ht
assay
direct
benefit
drug
develop
drug
design
counter
reovirus
arbovirus
diseas
therebi
posit
impact
widespread
burden
diseas
effect
dmso
cell
viabil
h
post
seed
cell
seed
treat
differ
concentr
dmso
percentag
cell
viabil
express
luminesc
signal
unit
per
well
line
indic
level
luminesc
signal
cell
dmso
treatment
experi
repeat
three
time
data
point
repres
averag
valu
replic
effect
seed
cell
densiti
fb
concentr
dmem
media
bsr
cell
cell
viabil
express
luminesc
signal
unit
per
well
cell
seed
plate
differ
cell
densiti
differ
fb
concentr
dmem
media
fb
concentr
figur
fb
concentr
figur
cell
viabil
measur
differ
time
post
seed
express
luminesc
signal
per
well
use
celltiterglo
reagent
h
post
seed
data
cell
densiti
cell
well
shown
figur
experi
repeat
three
time
data
point
repres
averag
valu
replic
averag
zvalu
averag
signaltobackground
sb
ratio
screen
nih
mlsmr
collect
dot
repres
zvalu
sb
b
one
plate
primari
ht
line
figur
repres
averag
zvalu
sb
obtain
averag
total
plate
whole
ht
percentag
inhibit
viru
induc
cpe
compound
ht
mlsmr
compound
librari
dot
repres
one
compound
librari
total
six
batch
plot
higher
line
inhibit
viru
induc
cpe
calcul
averag
inhibit
lower
line
plu
three
time
standard
deviat
inhibit
compound
entir
mlsmr
screen
activ
total
number
activ
compound
contain
given
substructur
sd
set
total
number
compound
contain
given
substructur
within
entir
singl
dose
screen
librari
enrich
meant
comput
enrich
ratio
antivir
assay
btv
valid
twice
use
compound
librari
primari
ht
btv
carri
via
screen
compound
nih
mlsmr
result
valid
primari
screen
summar
compar
tabl
number
hit
hit
rate
express
two
data
set
one
set
express
mean
inhibit
cpe
plu
three
time
standard
deviat
vari
assay
assay
screen
ii
screen
anoth
set
express
inhibit
viru
induc
cpe
n
number
compound
screen
z
averag
zvalu
plate
screen
cv
coeffici
variat
sb
ratio
signaltobackground
ratio
antivir
re
author
manuscript
avail
pmc
septemb
